Literature DB >> 10987729

Influenza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season.

H M Radwan1, S H Cheeseman, K K Lai, R T Ellison III.   

Abstract

A cluster of cases of severe influenzal disease was recognized in HIV-infected individuals during the 1997-1998 influenza season. Both primary influenza pneumonia and concomitant viral and bacterial pneumonia were found.

Entities:  

Mesh：

Year:  2000        PMID： 10987729     DOI： 10.1086/313985

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  26 in total

Review 1.  Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature.

Authors:  Anandi N Sheth; Keri N Althoff; John T Brooks
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

Review 2.  Influenza.

Authors:  John H Beigel
Journal:  Crit Care Med       Date:  2008-09       Impact factor: 7.598

Review 3.  Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.

Authors:  Ken M Kunisaki; Edward N Janoff
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

Review 4.  Vaccination in HIV-infected adults.

Authors:  Nancy F Crum-Cianflone; Mark R Wallace
Journal:  AIDS Patient Care STDS       Date:  2014-07-16       Impact factor: 5.078

5.  Pandemic influenza is a strong motivator for participation in vaccine clinical trials among HIV-positive Canadian adults.

Authors:  Mb Kiberd; C Cooper; Jm Slaunwhite; B Halperin; D Haase; Sa McNeil
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

6.  Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals.

Authors:  Jason Ho; Susan Moir; Wei Wang; Jacqueline G Posada; Wenjuan Gu; Muhammad T Rehman; Robin Dewar; Colin Kovacs; Michael C Sneller; Tae-Wook Chun; Dean A Follmann; Anthony S Fauci
Journal:  AIDS       Date:  2011-01-28       Impact factor: 4.177

7.  Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults.

Authors:  P Durando; D Fenoglio; A Boschini; F Ansaldi; G Icardi; L Sticchi; A Renzoni; P Fabbri; A Ferrera; A Parodi; B Bruzzone; G Gabutti; A Podda; G Del Giudice; E Fragapane; F Indiveri; P Crovari; R Gasparini
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

8.  A review of influenza vaccine immunogenicity and efficacy in HIV-infected adults.

Authors:  Curtis Cooper; Brian Hutton; Dean Fergusson; Edward Mills; Marina B Klein; Guy Boivin; Scott Halperin
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-11       Impact factor: 2.471

9.  High level antibody avidity is achieved in HIV-seropositive recipients of an inactivated split adjuvanted (AS03A) influenza vaccine.

Authors:  Karen K Yam; Erica Gipson; Marina Klein; Sharon Walmsley; David Haase; Scott Halperin; David Scheifele; Brian J Ward; Curtis Cooper
Journal:  J Clin Immunol       Date:  2014-05-14       Impact factor: 8.317

10.  Fatal case of pneumonia associated with pandemic (H1N1) 2009 in HIV-positive patient.

Authors:  Natalie C Klein; Azfar Chak; Marilyn Chengot; Diane H Johnson; Burke A Cunha
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.